Review of subject
The role of pharmacotherapy in the management of behaviour disorders in traumatic brain injury patients

References

• DEB, S., LYONS, I. and KOUTZOUKIS, C.: Neurobehavioural symptoms one year after a head injury. British Journal of Psychiatry, 174: 360–365, 1999.
   PubMed Web of Science ®Google Scholar
• JENNETT, B. and BOND, M.: Assessment of outcome after severe brain injury: a practical scale. Lancet, I: 480–485, 1975.
   Google Scholar
• AFFLECK, J. W., AITKEN, R. C. B., HUNTER, J. A. A. et al.: Rehabilitation status: a measure of medicosocial dysfunction. Lancet, I: 230–233, 1988.
   Google Scholar
• LEWIS, G., PELOSIA. J., ARAYA, R. C. et al.: Measuring psychiatric disorder in the community: a standardized assessment for use by lay interviewers. Psychological Medicine, 22: 465–486, 1992.
   Google Scholar
• HALE, M. S. and DONALDSON, J.: Lithium carbonate in the treatment of organic brain syndrome. Journal of Nervous and Mental Disorders, 170: 362–365, 1982.
   PubMed Web of Science ®Google Scholar
• SCHIFF, H. B., SABIN, T. D., GELLER, A. et al.: Lithium in aggressive behaviour. American Journal of Psychiatry, 139: 1346–1348, 1982.
   PubMed Web of Science ®Google Scholar
• HAAS, J. P. and COPE, D. V.: Neurophannacologic management of behavioural sequelae in head injury: a case report. Archives of Physical Medical Rehabilitation, 66: 472–474, 1985.
   PubMed Web of Science ®Google Scholar
• PARMALEE, D. X. and CYSHANICK, G. J.: Carbamazepine-lithium toxicity in brain-damaged ado-lescents. Brain Injury, 2: 305–308, 1988.
   PubMedGoogle Scholar
• GLENN, M. B.,WROBLEWSKI, B., PARZIALE, J. et al.: Lithium carbonate for aggressive behaviour or affective instability in ten brain-injured patients. American Journal of Physical Medical Rehabilitation, 68: 221–226, 1989.
   Google Scholar
• BELLUS, S. B., STEWART, D., VERGO, J. G. et al.: The use of lithium in the treatment of aggressive behaviours with two brain-injured individuals in a state psychiatric hospital. Brain Injury, 10: 849–860, 1996.
   PubMed Web of Science ®Google Scholar
• STANISLAV, S. W: Cognitive effects of antipsychotic agents in persons with traumatic brain injury. Brain Injury, 11: 335–341, 1997.
   PubMed Web of Science ®Google Scholar
• STANISLAV, S. W. and CHILDS, A.: Evaluating the usage of droperidol in acutely agitated persons with brain injury. Brain Injury, 14: 261–265, 2000.
   PubMed Web of Science ®Google Scholar
• MICHALS, M. L., CRISMON, M. L., ROBERT S. et al.: Clozapine response and adverse effects in nine brain-injured patients. Journal of Clinical Psychopharmacology, 13: 198–203, 1993.
   PubMed Web of Science ®Google Scholar
• MARYNIAK, O., MANCHANDA, R. and VELANI, A.: Methotrimeprazine in the treatment of agita-tion in acquired brain injury patients. Brain Injury, 15: 167–174, 2001.
   PubMed Web of Science ®Google Scholar
• MEYTHALER, J. M., DEPALMA, L., DEVIVO, M. J. et al.: Sertraline to improve arousal and alertness in severe traumatic brain injury secondary to motor vehicle crashes. Brain Injury, 15: 321–331, 2001.
   PubMed Web of Science ®Google Scholar
• FANN, J. R., UOMOTO, J. M. and KATON, W. J.: Sertraline in the treatment of major depression following mild traumatic brain injury. Journal of Neuropsychiatry and Clinical Neurosciences, 12: 226–232, 2000.
   PubMed Web of Science ®Google Scholar
• KANT, R., SMITH-SEEMILLER, L. and ZEILER, D.: Treatment of aggression and irritability after head injury. Brain Injury, 12: 661–666, 1998.
   Google Scholar
• NEWBURN, G., EDWARDS, R., THOMAS, H. et al.: Moclobemide in the treatment of major depres-sive disorder (DSM-3) following traumatic brain injury. Brain Injury, 13: 637–642, 1999.
   Google Scholar
• WROBLEWSKI, B. A., MCCOLGAN, K., SMITH, K. et al.: The incidence of seizures during tricyclic antidepressant drug treatment in a brain-injured population. Journal of Clinical Psychopharmacology, 10: 124–128, 1990.
   PubMed Web of Science ®Google Scholar
• MULLER, U., MURA T., BAUER-WITTMUND, T. et al.: Paroxetine versus citalopram treatment of pathological crying after brain injury. Brain Injury, 13: 805–811, 1999.
   Google Scholar
• ALLMAN, P.: Drug treatment of emotionalism following brain damage (letter). Journal of the Royal Society of Medicine, 85: 423–424, 1992.
   PubMed Web of Science ®Google Scholar
• ROWLAND, T., MYSIW, W. J., BOGNER, J. et al.: Trazodone for post traumatic agitation. Archives of Physical Medical Rehabilitation, 73: 963, 1992.
   Google Scholar
• RANEN, N. G., LIPSEY, J. R.,TREISMAN, G. et al.: Sertraline in the treatment of severe aggressiveness in Huntingdon's disease. Journal of Neuropsychiatry and Clinical Neurosciences, 8: 338–340, 1996.
   Google Scholar
• REINHARD, D. L., WHYTE, J. and SANDEL, E.: Improved arousal and initiation following tricyclic antidepressant use in severe brain injury. Archives of Physical Medical Rehabilitation, 77: 80–83, 1996.
   PubMed Web of Science ®Google Scholar
• SLAUGHTER, J., Bolsi:), W. and CHILDERS, M. K.: Selective serotonin reuptake inhibitor treatment of post-traumatic Kluver-Bucy syndrome. Brain Injury, 13: 59–62, 1999.
   Google Scholar
• HAMILTON, M.: A rating scale for depression.Journal of Neurology, Neurrosurgery, and Psychiatry, 23: 56–62, 1960.
   PubMed Web of Science ®Google Scholar
• DEB, S., LYONS, I., KOUTZOUKIS, C. et al.: Rate of psychiatric illness one year after traumatic brain injury. American Journal of Psychiatry, 156: 374–378, 1999.
   PubMed Web of Science ®Google Scholar
• DEN BOER, J. A., BOSKER, F. J. and SiAAP, B. R.: Serotonergic drugs in the treatment of depressive and anxiety disorders. Human Psychopharmacology, 15: 315–336, 2000.
   PubMed Web of Science ®Google Scholar
• SPEECH, T. J., RAO, S. M., OSMON, D. C. et al.: A double-blind controlled study of methylphe-nidate treatment in closed head injury. Brain Injury, 7: 333–338, 1993.
   PubMedGoogle Scholar
• MOONEY, G. F. and HAAS, L. J.: Effect of methylphenidate on brain injury related anger. Archives of Physical Medical Rehabilitation, 74: 153–160, 1993.
   PubMed Web of Science ®Google Scholar
• PLENGER, P. M., DIXON, C. E., CASTILLO, R. M. et al.: Subacute methylphenidate treatment for moderate to moderately severe traumatic brain injury: a preliminary double blind placebo-con-trolled study. Archives of Physical Medical Rehabilitation, 77: 536–540, 1996.
   PubMed Web of Science ®Google Scholar
• WHYTE, J., HART, T., SCHUSTER, K. et al.: Effects of methylphenidate on attentional function after traumatic brain injury. A randomised, placebo-controlled trial. American Journal of Physical Medical Rehabilitation, 76: 440–450, 1997.
   PubMed Web of Science ®Google Scholar
• GUALTIERI, C. T and EVANS, R. W.: Stimulant treatment for the neurobehavioural sequelae of traumatic brain injury. Brain Injury, 2: 273–290, 1988.
   PubMedGoogle Scholar
• WROBLEWSKI, B. A., LEARY, J. M., PHELAN, A. M. et al.: Methylphenidate and seizure frequency in brain injured patients with seizure disorders. Journal of Clinical Psychiatry, 53: 86–89, 1992.
   PubMed Web of Science ®Google Scholar
• HORNSTEIN, A., LENNIHAN, L., SELIGER, G. et al.: Amphetamine in recovery from brain injury. Brain Injury, 10: 145–148, 1995.
   Web of Science ®Google Scholar
• EVANS, R. W, GUALTIERI, C. T and PATTERSON, D.: Treatment of chronic closed head injury with psychostimulant drugs: a controlled case study and an appropriate evaluation procedure. Journal of Nervous and Mental Disorders, 175: 106–110, 1987.
   PubMed Web of Science ®Google Scholar
• DIKMEN, S. S., MACHAMER, M. A.,WINN, H. R. et al.: Neuropsychological effects of valproate in traumatic brain injury: a randomised trial. Neurology, 54: 895–902, 2000.
   Google Scholar
• SMITH, K. R., GOULDING, P. M., WILDERMAN, D. et al.: Neurobehaviourg effects of phenytoin and carbamazepine in patients recovering from brain trauma. Archives of Neurology, 51: 653–660, 1994.
   PubMedGoogle Scholar
• PERINO, C., RAGO, R., CICOLIN, A. et al.: Mood and behavioural disorders following traumatic brain injury: clinical evaluation and pharmacological management. Brain Injury, 15: 139–148, 2001.
   PubMed Web of Science ®Google Scholar
• CHALTHAM SHOWALTER, P. E. and KIMMEL, D. N.: Agitated symptom response to divalproax following acute brain injury. The Journal of Neuropsychiatry and Clinical Neurosciences, 12: 395–397, 2000.
   PubMed Web of Science ®Google Scholar
• KIM, E. and HUMARAN, T. J.: Divalproax in the management of neuropsychiatric complications of remote acquired brain injury. The Journal of Neuropsychiatry and Clinical Neurosciences, 14: 202–205, 2002.
   PubMed Web of Science ®Google Scholar
• Azouvi, P., Joxic, C., ATTAL, N. et al.: Carbamazepine in agitation and aggressive behaviour following severe closed-head injury: results of an open trial. Brain Injury, 13: 797–804, 1999.
   PubMed Web of Science ®Google Scholar
• Pop, H. G., MCELROY, S. L., SATLIN, A. et al.: Head injury, bipolar disorder and response to valproate. Comprehensive Psychiatry, 29: 34–38, 1988.
   PubMed Web of Science ®Google Scholar
• STEWART, J. T. and HEMSATH, R. H.: Bipolar illness following traumatic brain injury: treatment with lithium and carbamazepine. Journal of Clinical Psychiatry, 49: 74–75, 1988.
   PubMed Web of Science ®Google Scholar
• GERACIOTI, T. D.: Valproic acid treatment of episodic explosiveness related to brain injury. Journal of Clinical Psychiatry, 55: 416–417, 1994.
   PubMed Web of Science ®Google Scholar
• HORNE, M. and LINDLEY, S. E.: Divalproex sodium in the treatment of aggressive behaviour and dysphoria in patients with organic brain syndromes (letter). Journal of Clinical Psychiatry, 56: 430–431, 1995.
   PubMed Web of Science ®Google Scholar
• CHATHAM-SHOWALTER, P. E.: Carbamazepine for combativeness in acute traumatic brain injury. Journal of Neuropsychiatry and Clinical Neurosciences, 8: 96–99, 1996.
   PubMed Web of Science ®Google Scholar
• WROBLEWSKI, B. A., JOSEPH, A. B., KUPFER, J. et al.: Effectiveness of valproic acid on destructive and aggressive behaviours in patients with acquired brain injury. Brain Injury, 11: 37–47, 1997.
   PubMed Web of Science ®Google Scholar
• CHATHAM-SHOWALTER, P. E. and NETSKY KIMMEL, D.: Stimulating consciousness and cognition following severe brain injury: a new potential clinical use for lamotrigine. Brain Injury, 14: 997–1001, 2000.
   Google Scholar
• STANISLAV, S. W, FABRE, T., CRISMON, M. L. et al.: Buspirone's efficacy in organic-induced aggression. Journal of Clinical Psychopharmacology, 14: 126–130, 1994.
   PubMed Web of Science ®Google Scholar
• GUALTIERI, C. T.: Buspirone for the behaviour problems of patients with organic brain disorder (letter). Journal of Clinical Psychopharmacology, 11: 280–281, 1991.
   PubMed Web of Science ®Google Scholar
• GUALTIERI, C. T.: Buspirone: neuropsychiatric effects. Journal of Head Trauma Rehabilitation, 6: 90–92, 1991.
   Google Scholar
• RATEY, J. J., LEVERONI, C. L., MILLER, A. C. et al.: Low-dose buspirone to treat agitation and maladaptive behaviour in brain-injured patients: two case reports (letter). Journal of Clinical Psychopharmacology, 12: 362–364, 1992.
   PubMed Web of Science ®Google Scholar
• SCHNEIDER, W. N., DREW-CATES, J., WONG, T. M. et al.: Cognitive and behavioural efficacy of amantadine in acute traumatic brain injury: an initial double-blind placebo-controlled study. Brain Injury, 13: 863–872, 1999.
   Google Scholar
• MEYTHALER, J. M., BRUNER, R. C., JOHNSON, A. et al.: Amantadine to improve neurorecovery in traumatic brain injury-associated diffuse axonal injury: a pilot double-blind randomised trail. Journal of Head Trauma Rehabilitation, 17: 300–313, 2002.
   PubMed Web of Science ®Google Scholar
• KRAUS, M. F. and MAKI, P.: The combined use of amantadine and 1-dopa/carbidopa in the treatment of chronic brain injury. Brain Injury, 11: 455–460, 1996.
   Google Scholar
• KARLI, D. C., BURKE, D. T., KIM, H. J. et al.: Effects of dopaminergic combination therapy for frontal lobe dysfunction in traumatic brain injury rehabilitation. Brain Injury, 13: 63–68, 1998.
   Web of Science ®Google Scholar
• ZAFONTE, R. D., WATANABE, T and MANN, N. R.: Amantadine: a potential treatment for the minimally conscious state. Brain Injury, 12: 617–621, 1998.
   Google Scholar
• GREENDYKE, R. M., KANTER, D. R., SCHUSTER, D. B. et al.: Propranolol treatment of assaultative patients with organic brain disease. A double-blind crossover, placebo-controlled study. Journal of Nervous and Mental Disorders, 174: 290–294, 1986.
   PubMed Web of Science ®Google Scholar
• GREENDYKE, R. M. and KANTER, D. R.: Therapeutic effects of pindolol on behavioural distur-bances associated with organic brain disease. A double blind study . Journal of Clinical Psychiatry, 47: 423–426, 1986.
   Google Scholar
• BROOKE, M. M., PATTERSON, D. R., QUESTAD, K. A. et al.: The treatment of agitation during initial hospitalization after traumatic brain injury. Archives of Physical Medical Rehabilitation, 73: 917–921, 1992.
   PubMed Web of Science ®Google Scholar
• GREENDYKE, R. M., SCHUSTER, D. B. and WOONTON, J. A.: Propranolol in the treatment of assaultative patients with organic brain disease. Journal of Clinical Psychopharmacology, 4: 282–285, 1984.
   PubMed Web of Science ®Google Scholar
• MATTES, J.A.: Metoprolol for intermittent explosive disorder. American Journal of Psychiatry, 142: 1108–1109, 1985.
   PubMed Web of Science ®Google Scholar
• EMORY, L. E., COLE, C. M. andMEYER,W. J.: Use of Depo-Provera to control sexual aggression in persons with traumatic brain injury. Journal of Head Trauma Rehabilitation, 10: 47–58, 1995.
   Web of Science ®Google Scholar
• ARNOLD, S. E.: Estrogen for refractory aggression after traumatic brain injury. American Journal of Psychiatry, 150: 1564–1565, 1993.
   PubMed Web of Science ®Google Scholar
• BRITTON, K. R.: Medroxyprogesterone in the treatment of aggressive hypersexual behaviour in traumatic brain injury. Brain Injury, 12: 703–707, 1998.
   PubMed Web of Science ®Google Scholar
• EAMES, P. and LIWOOD, R.: Lysine vasopressin in post-traumatic memory disorders: an uncon-trolled pilot study. Brain Injury, 13: 255–260, 1999.
   PubMed Web of Science ®Google Scholar
• TAVERNI, J. P., SELIGER, G. and LICHTMAN, S. W.: Donepezil mediated memory improvement in traumatic brain injury during post acute rehabilitation. Brain Injury, 12: 77–80, 1997.
   Web of Science ®Google Scholar
• MASANIC, C., BAYLEY, M. T., VAN REEKUM, R. et al.: Open-label study of donepezil in traumatic brain injury. Archives of Physical Medicine and Rehabilitation, 82: 896–901, 2001.
   PubMed Web of Science ®Google Scholar
• CALVANIO, R., BURKE, D. T., KIM, H. J.. et al.: Naltrexone: effects on motor function, speech, and activities of daily living in a patient with traumatic brain injury. Brain Injury, 14: 933–942, 2000.
   PubMed Web of Science ®Google Scholar
• DENMARK, J. and GEMEINHARD, M.: Anger management for survivors of acquired brain injury. Brain Injury, 16: 91–108, 2002.
   PubMed Web of Science ®Google Scholar